108 results match your criteria: "Heart Center Munich-Bogenhausen[Affiliation]"
Acta Radiol
April 2015
Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA.
Background: Monoenergetic extrapolation of cardiac dual-energy computed tomography (DECT) could be useful in artifact reduction in clinical practice.
Purpose: To evaluate the potential of monoenergetic extrapolation of cardiac DECT data for reducing artifacts from metal and high iodine contrast concentration.
Material And Methods: With IRB approval and in HIPAA compliance, 35 patients (22 men, 61 ± 12 years) underwent cardiac DECT with dual-source CT (100 kVp and 140 kVp).
Circ Arrhythm Electrophysiol
April 2014
Department of Cardiology and Internal Intensive Care Medicine, Heart Center Munich-Bogenhausen, Munich Municipal Hospital Group, Munich, Germany.
Background: Cryoballoon (CB) ablation results in >70% freedom from atrial fibrillation at 1 year. Single-center data of the first (CBG1) and second (CBG2) cryoballoon, recently introduced, were analyzed to compare safety and efficacy.
Methods And Results: From March 2011 to December 2012, CB ablation with spiral mapping was performed consecutively in 484 patients with symptomatic atrial fibrillation.
Radiology
February 2014
From the Department of Radiology and Radiological Science (A.S., R.V., U.J.S., P.B., U.E., Y.J.C., C.F., P.A.) and Division of Cardiology (U.J.S., U.E.) Medical University of South Carolina, Ashley River Tower, 25 Courtenay Dr, MSC 226, Charleston, SC 29401; Institute of Clinical Radiology, Ludwig-Maximilian-University Hospital, Munich, Germany (A.S., T.S., F.B., K.N.); Center for Medical Imaging-North East Netherlands (R.V.) and Department of Radiology (R.V.), University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Department of Diagnostic Radiology, University Hospital Freiburg, Freiburg, Germany (P.B.); Department of Cardiology and Intensive Care Medicine, Heart Center Munich-Bogenhausen, Munich, Germany (U.E.); Siemens Healthcare, CT Division, Forchheim, Germany (T.A., S.V., R.R.); and Institute of Clinical Radiology and Nuclear Medicine, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany (C.F., P.A.).
Purpose: To investigate in vitro and in vivo the use of image-based and raw data-based iterative reconstruction algorithms for quantification of coronary artery calcium by using the Agatston score and subsequent cardiac risk stratification.
Materials And Methods: In vitro data were obtained by using a moving anthropomorphic cardiac phantom containing calcium inserts of different concentrations and sizes. With institutional review board approval and HIPAA compliance, coronary calcium imaging data of 110 consecutive patients (mean age ± standard deviation, 58.
Acad Radiol
March 2014
Heart and Vascular Center, Medical University of South Carolina, Ashley River Tower, 25 Courtenay Drive, Charleston, SC, 29425-2260; Department of Cardiology and Intensive Care Medicine, Heart Center Munich-Bogenhausen, Munich, Germany.
Rationale And Objectives: To investigate the impact of iterative reconstruction in image space (IRIS) on image noise, image quality (IQ), and postprocessing at coronary computed tomography angiography (cCTA) compared to traditional filtered back-projection (FBP).
Materials And Methods: The cCTA results of 50 patients (26 men; 58 ± 15 years, body mass index 31.5 ± 6.
Am J Cardiol
February 2014
Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, South Carolina; Department of Radiology, Center for Medical Imaging-North East Netherlands, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Disparities in the risk of coronary artery disease (CAD) between races may be influenced by differences in the thoracic adipose tissue. We compared computed tomography (CT)-derived volumes of epicardial adipose tissue (EAT), mediastinal adipose tissue (MAT), and pericoronary fat thickness (PFT) and correlations with CAD between black and white patients. This institutional review board-approved Health Insurance Portability and Accountability Act-compliant study included 372 age- and gender-matched black versus white patients (186 black, 54 ± 11 years, 50% men; 186 white, 54 ± 11 years, 50% men) who underwent CT for chest pain evaluation.
View Article and Find Full Text PDFInt J Cardiol
October 2013
Schulich Heart Center at Sunnybrook Health Science Center Toronto, Univ. of Toronto, Canada; Heart Center Munich Bogenhausen at Klinikum München Bogenhausen, Dept. of Cardiology, Munich, Germany. Electronic address:
Aims: Prospective data on the usage of 3-dimensional imaging based annulus sizing on the outcome of TAVI is not available yet and there is general uncertainty about the optimal degree of oversizing. In the current study we therefore assessed a 3-D MSCT guided over-sizing approach and evaluated the clinical outcome of different degrees of oversizing.
Methods: TAVI-size-selection was done using systolic MSCT-annulus cross-sectional-area (CSA) measurements in 107 patients with severe aortic stenosis with the goal to oversize the 3rd generation balloon expandable Edwards Sapien XT (ESTV) device in relation to the native aortic annulus CSA.
J Interv Card Electrophysiol
December 2011
Department of Cardiology an Intensive Care Medicine, Heart Center Munich-Bogenhausen, Klinikum Bogenhausen, Englschalkinger Strasse 77, 81925, Munich, Germany.
Expert Opin Pharmacother
April 2008
Heart Center Munich-Bogenhausen, Department of Cardiology and Intensive Care Unit, Klinikum Bogenhausen, Städtisches Klinikum München GmbH, Englschalkinger Strasse 77, 89125 Munich, Germany.
Background: Atrial fibrillation is the most common sustained arrhythmia observed worldwide. Despite modern ablative treatment options, pharmacotherapy remains the first-line therapy in patients with atrial fibrillation.
Objective: Based on recently published guidelines for the management of atrial fibrillation, the present paper reviews the current and emerging concepts of pharmacotherapy in atrial fibrillation.